GCCL Co., Ltd. (GCCL), a global clinical trial laboratory services provider, announced that it will attend World Vaccine Congress 2026 (WVC 2026), taking place from March 30 to April 2 in Washington, ...

Inherited variations in antibody genes can affect how we respond to infections and vaccines, show two new studies from ...

A study has found that repeat vaccination with updated versions of the COVID-19 vaccine promotes the development of antibodies that neutralize a wide range of variants of the virus that causes ...

Antibodies are small proteins that are secreted by specialized cells to target and neutralize pathogens. The “Y” shaped structure is crucial for active immunity and work by binding and tagging ...

An HIV vaccine candidate developed at the Duke Human Vaccine Institute (DHVI) triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a ...

LA JOLLA, CA and NEW YORK, NY—A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of ...

Researchers have developed a GPS vaccine that guides the immune system to create broadly neutralizing antibodies against HIV. For many years, researchers have been trying to develop an HIV vaccine ...